Bristol-Myers Squibb Co. (NYSE: BMY) shares rose in early trade today on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.
Meanwhile stocks opened fat this morning as investors wait on the minutes from the Federal Reserve’s latest policy meeting, which may confirm expectations for a December rate hike.
The S&P 500 was up 2 points, or 0.1%, to 2,138. The Dow Jones Industrial Average was flat at 18,128. The Nasdaq Composite began the session unchanged at 5,247.
Analysts at Barclays PLC reiterated an Equal Weight rating on shares of Bristol-Myers Squibb Co. (NYSE: BMY) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street. With a rating of Equal Weight on the stock, Bristol-Myers Squibb Co. has a 52-week high of $77.12. As a means of comparison, a number of other analysts have commented on the stock recently, and Bristol-Myers Squibb Co. has earned a consensus one-year price target of $66.75, higher than the opening price of $49.82, a difference of 13.15 percent. Usually, after analysts give a “reiterated rating” report on a stock, they will subsequently issue periodic updates, usually followed by a price target change.
Bristol-Myers Squibb Co. (NYSE: BMY) shares last traded at $50.75, a spike of $1.20 or 0.02 from the previous closing price. Opening at $49.82, they varied from $49.74 and $50.75 throughout the day.
Bristol-Myers Squibb Co. (NYSE: BMY) currently has a market cap of 84.80B.
Bristol-Myers Squibb Co.Trading Volume
The stock’s average daily volume is 13,252,900 shares out of a total float 1,539,495,000 and some 3,280,731 shares traded hands yesterday, lower than the norm. Trading volume is likely to increase in the next few days as momentum traders often use swings in trading volume to identify large volume growth or distribution by institutional investors.
However, just a day of significant buy side trading is not enough to determine a trend. So market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.
Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.
Institutional investors such as these retain substantial teams of analysts researching thousands of stocks, so it is good validation to see them taking a postion in a stock you are considering.
Bristol-Myers Squibb Co. Moving Averages
A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of successful trades.
Trades for Bristol-Myers Squibb Co. (NYSE: BMY) have ranged from $49.50 – 77.12, and the stock now has a 50-day MA of $55.86 and 200-day MA of $66.63. Today’s last price is 0.34% below the 52 week high of $77.12.
Earnings growth is a crucial factor to look at when investing in stocks and investors watch for companies that have increased their earnings by at least 25% over the past 3 years.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.